Market Place
Sourcing Support
All News #Library
Samsung Bioepis’s Biologics Opuviz Recives Suppl Approval in US
25 Aug 2025 //
FDA
Samsung Bioepis`s Biologics Opuviz Receives Suppl Approval in US
06 Jun 2025 //
FDA
Samsung Bioepis`s Biologics Hadlima Receives Suppl Approval in US
21 May 2025 //
FDA
Samsung Bioepis`s Biologic Xbryk Receives Approval in US
14 Feb 2025 //
FDA
Samsung Bioepis`s Biologic Epysqli Receives Suppl Approval in US
15 Nov 2024 //
FDA
Samsung Bioepis`s Eksunbi (ustekinumab) Receives Approval in Europe
12 Sep 2024 //
EMA
Samsung Bioepis`s Biologic Epysqli (Eculizumab) Receives Approval in US
19 Jul 2024 //
FDA
Samsung Bioepis` Eticovo (etanercept-ykro) Receives Suppl Approval in U.S.
03 May 2024 //
FDA
Samsung`s Biologic Hadlima (Adalimumab) Receives Approval in the U.S.
11 Jul 2023 //
FDA
Samsung`s Biologic Byooviz (Ranibizumab) Receives Approval in the U.S.
16 Jun 2023 //
FDA
Samsung Bioepis`s Epysqli (Eculizumab) Receives Approval in the Europe
31 May 2023 //
EMA
Samsung`s Biologic Hadlima (Adalimumab) Receives Approval in the U.S.
23 Dec 2022 //
FDA
Samsung`s Biologic Byooviz (Ranibizumab-Nuna) Receives Approval in the U.S.
15 Aug 2022 //
FDA
Samsung`s Biologic Hadlima (Adalimumab-Bwwd) Receives Approval in the U.S.
15 Aug 2022 //
FDA
Samsung Bioepis`s Biologic Ranibizumab-Nuna Receives Approval in US
20 Sep 2021 //
FDA
Samsung Bioepis`s Byooviz (ranibizumab) Receives Approval in Europe
18 Aug 2021 //
EMA
Samsung Bioepsis` Trastuzumab-Dttb Receives Supplemtl Approval in US
18 Jan 2019 //
FDA
Samsung Bioepis UK Ontruzant (trastuzumab) Receives Approval In Europe
27 Jan 2018 //
EMA
Samsung Bioepis UK`s Imraldi (adalimumab) Receives Approval in Europe
01 Sep 2017 //
EMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.